Sept 7 (Reuters) - Vetoquinol SA VETO.PA :
* H1 NET INCOME - GROUP SHARE: €32M (12.6% OF SALES)
* H1 SALES: EUR 256 MILLION (-5.4% AS REPORTED)
* H1 EBITDA*: €54M (20.9% OF SALES)
* H1 ESSENTIALS PRODUCTS SALES: €151M (59% OF GROUP SALES)
* EBIT BEFORE AMORTIZATION OF INTANGIBLE ASSETS ACQUIRED
AMOUNTED
TO €45 MILLION FOR THE YEAR ENDED JUNE 30, 2023
* SAYS SALES IN EUROPE WERE NOTABLY IMPACTED BY A DOWNTURN
IN THE
LIVESTOCK ANTIBIOTICS MARKET
* SAYS EUROPE AND ASIA/PACIFIC/REST OF WORLD TERRITORIES
WERE DOWN
BY -5.4% AND -16.3% RESPECTIVELY AT CONSTANT EXCHANGE RATES
Source text: https://tinyurl.com/2p8hr2nb
Further company coverage: VETO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))